Literature DB >> 8514039

Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites.

A Ginès1, A Escorsell, P Ginès, J Saló, W Jiménez, L Inglada, M Navasa, J Clària, A Rimola, V Arroyo.   

Abstract

BACKGROUND: The aim of the study was to investigate the incidenc, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites.
METHODS: The study is a follow-up investigation in 234 nonazotemic patients with cirrhosis and ascites. Thirty-nine variables obtained at inclusion were analyzed as possible predictors of hepatorenal syndrome occurrence (Kaplan-Meier method, Mantel-Cox test, and step-wise Cox regression procedure).
RESULTS: The probability of hepatorenal syndrome occurrence was 18% at 1 year and 39% at 5 years. Sixteen variables had predictive value for hepatorenal syndrome occurrence in the univariate analysis: history of ascites, hepatomegaly, nutritional status, blood urea nitrogen level, serum creatinine concentration, serum sodium and potassium concentration, serum and urine osmolality, urinary sodium excretion, free water clearance after a water load, glomerular filtration rate, arterial pressure, plasma renin activity, plasma norepinephrine concentration, and esophageal varices. Neither etiology (alcoholic vs. nonalcoholic) nor the Child-Pugh score had predictive value. A multivariate analysis disclosed only three independent predictors of hepatorenal syndrome occurrence: low serum sodium concentration, high plasma renin activity, and absence of hepatomegaly.
CONCLUSIONS: The hepatorenal syndrome is a relatively frequent complication in cirrhotic patients with ascites that is associated with an extremely short survival. Liver size, plasma renin activity, and serum sodium concentration are predictors of hepatorenal syndrome occurrence in these patients.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8514039     DOI: 10.1016/0016-5085(93)90031-7

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  146 in total

Review 1.  Transjugular portosystemic stent shunt in treatment of liver diseases.

Authors:  M Schepke; T Sauerbruch
Journal:  World J Gastroenterol       Date:  2001-04       Impact factor: 5.742

Review 2.  The hepatorenal syndrome.

Authors:  L Dagher; K Moore
Journal:  Gut       Date:  2001-11       Impact factor: 23.059

Review 3.  Integration of palliative care in end-stage liver disease and liver transplantation.

Authors:  Jamie Potosek; Michael Curry; Mary Buss; Eva Chittenden
Journal:  J Palliat Med       Date:  2014-11       Impact factor: 2.947

4.  Hepatorenal Syndrome.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  2000-12

5.  Effects of orthotopic liver transplantation on vasoactive systems and renal function in patients with advanced liver cirrhosis.

Authors:  Concepcíon Cassinello; Enrique Moreno; Adolfo Gozalo; Blanca Ortuño; Beatriz Cuenca; José Antonio Solís-Herruzo
Journal:  Dig Dis Sci       Date:  2003-01       Impact factor: 3.199

6.  Impact of liver transplantation on the survival of patients treated for hepatorenal syndrome type 1.

Authors:  Thomas D Boyer; Arun J Sanyal; Guadalupe Garcia-Tsao; Frederick Regenstein; Lorenzo Rossaro; Beate Appenrodt; Veit Gülberg; Samuel Sigal; Alice S Bexon; Peter Teuber
Journal:  Liver Transpl       Date:  2011-11       Impact factor: 5.799

Review 7.  Kidney Failure and Liver Allocation: Current Practices and Potential Improvements.

Authors:  Varun Saxena; Jennifer C Lai
Journal:  Adv Chronic Kidney Dis       Date:  2015-09       Impact factor: 3.620

Review 8.  Renal dysfunction in cirrhosis: diagnosis, treatment and prevention.

Authors:  Elaine Yeung; Elaine Yong; Florence Wong
Journal:  MedGenMed       Date:  2004-12-02

9.  Clinical course and prognostic factors of hepatorenal syndrome: A retrospective single-center cohort study.

Authors:  Anna Licata; Marcello Maida; Ambra Bonaccorso; Fabio Salvatore Macaluso; Maria Cappello; Antonio Craxì; Piero Luigi Almasio
Journal:  World J Hepatol       Date:  2013-12-27

10.  Therapeutic alternatives for the treatment of type 1 hepatorenal syndrome: A Delphi technique-based consensus.

Authors:  Juan P Arab; Juan C Claro; Juan P Arancibia; Jorge Contreras; Fernando Gómez; Cristian Muñoz; Leyla Nazal; Eric Roessler; Rodrigo Wolff; Marco Arrese; Carlos Benítez
Journal:  World J Hepatol       Date:  2016-09-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.